News


Novavax vaccine is highly protective against COVID-19 in Phase 3 results

June 17, 2021

UT Health San Antonio collaborated with University Health as part of the international COVID-19 Prevention Network and enrolled 176 Novavax clinical trial participants in San Antonio for the Phase 3 study, which is called PREVENT-19.




Metal ions help COVID-19 virus to disguise itself

June 2, 2021

Scientists from The University of Texas Health Science Center at San Antonio have discovered a mechanism by which SARS-CoV-2 exploits changes in metal ion concentrations to disguise itself in the body. Varying concentrations of metal ions — positively charged atoms such as magnesium, manganese and calcium — are observed in hospitalized COVID-19 patients.




San Antonio partners pioneer surgery aimed at reversing Type 2 diabetes

April 23, 2021

The goal of the novel procedure is to improve the patients’ health and minimize or reverse the adverse health effects of their Type 2 diabetes.




UT Health San Antonio research team tackles childhood obesity with five-year, $1 million grant from Baptist Health Foundation

April 9, 2021

The potentially groundbreaking research led by principal investigator Lily Q. Dong, PhD, professor of cell systems and anatomy at UT Health San Antonio, is testing whether there is a genetic marker of early insulin resistance in youth that could be controlled, thereby preventing obesity and development of Type 2 diabetes. Currently, most studies and treatment […]



Trauma experts aim to reduce deaths by providing blood-clotting agent

March 31, 2021

Severely injured trauma patients who received a blood-clotting drug before arriving at the hospital had a better chance of surviving than those who didn’t, according to new research published in Journal of the American Medical Association Surgery.


UT Health San Antonio new hospital rendering

A cornerstone of research-based medicine

March 29, 2021

The University of Texas Health Science Center at San Antonio broke ground and unveiled the cornerstone for the UT Health San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of cancer and other complex diseases that disproportionately impact the people of South Texas.




Bladder cancer patients respond well to new immunotherapy tested at Mays Cancer Center

March 26, 2021

According to the study, 53.4% of participants receiving NF were free of cancer at three months and 45.5% of patients continued to be cancer-free for at least 12 months.




Early tracheotomy helps patients avoid ventilator-associated pneumonia, team finds

March 26, 2021

The surgery, called tracheotomy, is performed either in the operating room or at the bedside, depending on patient risk factors. The team analyzed 17 studies that included more than 3,000 patients.




COVID-19 nasal swab test may not be best for those who’ve had sinus surgery

March 26, 2021

People who have had major sinus surgery should consult their ENT doctor before undergoing COVID-19 swab testing, new research indicates. Switching to other testing may be warranted for safety.



Faculty member selected for diversity leadership program

March 5, 2021

Eduardo Marques Zilli, MD, assistant professor and neurologist with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, was recently selected to take part in the 2021 America Academy of Neurology Diversity Leadership Program.